UTERINE CERVICAL METAPLASIA

UTERINE CERVICAL METAPLASIA was reported 26 times

UTERINE CERVICAL METAPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Androgen [EPC] 8 0.0003
1 Copper-containing Intrauterine Device [EPC] 4 0.0001
2 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
3 Interferon beta [EPC] 1 0.0000
4 Vitamin C [EPC] 2 0.0000
5 Progestin [EPC] 1 0.0000
6 Vitamin D [EPC] 1 0.0000
7 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
8 Vitamin B12 [EPC] 1 0.0000
9 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
10 Corticosteroid [EPC] 1 0.0000